Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$268.87 - $324.56 $158,095 - $190,841
-588 Reduced 4.11%
13,705 $3.9 Million
Q4 2023

Jan 23, 2024

BUY
$255.7 - $288.46 $514,724 - $580,669
2,013 Added 16.39%
14,293 $4.12 Million
Q3 2023

Oct 16, 2023

BUY
$218.65 - $271.46 $11,588 - $14,387
53 Added 0.43%
12,280 $3.3 Million
Q2 2023

Jul 27, 2023

SELL
$214.27 - $253.37 $2,571 - $3,040
-12 Reduced 0.1%
12,227 $2.71 Million
Q1 2023

May 09, 2023

BUY
$225.79 - $275.2 $35,223 - $42,931
156 Added 1.29%
12,239 $2.96 Million
Q4 2022

Feb 02, 2023

SELL
$229.03 - $291.01 $1,374 - $1,746
-6 Reduced 0.05%
12,083 $3.17 Million
Q3 2022

Oct 19, 2022

SELL
$224.46 - $253.15 $1.57 Million - $1.77 Million
-7,007 Reduced 36.69%
12,089 $2.73 Million
Q2 2022

Jul 21, 2022

BUY
$230.71 - $256.74 $2.79 Million - $3.11 Million
12,111 Added 173.39%
19,096 $4.65 Million
Q1 2022

May 06, 2022

SELL
$219.27 - $242.57 $657 - $727
-3 Reduced 0.04%
6,985 $1.69 Million
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $744,430 - $872,190
-3,507 Reduced 33.42%
6,988 $1.49 Million
Q2 2021

Aug 09, 2021

SELL
$233.58 - $259.14 $1.52 Million - $1.69 Million
-6,506 Reduced 38.27%
10,495 $2.56 Million
Q1 2021

May 10, 2021

BUY
$221.91 - $258.6 $3.77 Million - $4.4 Million
17,001 New
17,001 $4.23 Million
Q4 2020

Feb 10, 2021

SELL
$216.38 - $257.67 $3.72 Million - $4.44 Million
-17,213 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$234.65 - $260.95 $8,916 - $9,916
38 Added 0.22%
17,213 $4.38 Million
Q2 2020

Aug 10, 2020

SELL
$197.81 - $242.74 $101,476 - $124,525
-513 Reduced 2.9%
17,175 $4.05 Million
Q1 2020

May 12, 2020

SELL
$182.24 - $241.7 $667,727 - $885,588
-3,664 Reduced 17.16%
17,688 $3.59 Million
Q4 2019

Feb 06, 2020

SELL
$189.21 - $243.2 $2.54 Million - $3.26 Million
-13,412 Reduced 38.58%
21,352 $5.15 Million
Q3 2019

Nov 08, 2019

SELL
$174.11 - $208.62 $764,517 - $916,050
-4,391 Reduced 11.21%
34,764 $6.73 Million
Q2 2019

Aug 12, 2019

BUY
$166.7 - $195.41 $19,503 - $22,862
117 Added 0.3%
39,155 $7.22 Million
Q1 2019

May 10, 2019

SELL
$180.87 - $203.88 $1.57 Million - $1.77 Million
-8,705 Reduced 18.23%
39,038 $7.42 Million
Q4 2018

Feb 08, 2019

SELL
$178.4 - $208.25 $952,477 - $1.11 Million
-5,339 Reduced 10.06%
47,743 $9.3 Million
Q3 2018

Nov 13, 2018

BUY
$185.29 - $208.89 $739,492 - $833,679
3,991 Added 8.13%
53,082 $11 Million
Q2 2018

Aug 09, 2018

SELL
$166.05 - $186.51 $549,293 - $616,975
-3,308 Reduced 6.31%
49,091 $9.06 Million
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $2.33 Million - $2.72 Million
-13,730 Reduced 20.76%
52,399 $8.93 Million
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $2.7 Million - $3.02 Million
16,022 Added 31.98%
66,129 $11.5 Million
Q3 2017

Nov 14, 2017

SELL
$167.29 - $191.0 $26.2 Million - $29.9 Million
-156,660 Reduced 75.77%
50,107 $9.34 Million
Q2 2017

Aug 07, 2017

BUY
N/A
206,767
206,767 $35.6 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Gam Holding Ag Portfolio

Follow Gam Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on Gam Holding Ag with notifications on news.